StockNews.com initiated coverage on shares of Veradigm (NASDAQ:MDRX – Free Report) in a research report report published on Friday morning. The brokerage issued a hold rating on the software maker’s stock.
Separately, Stephens upped their target price on shares of Veradigm from $7.00 to $13.00 and gave the company an “equal weight” rating in a research note on Friday, January 31st.
Check Out Our Latest Analysis on Veradigm
Veradigm Price Performance
Veradigm Company Profile
Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.
Featured Stories
- Five stocks we like better than Veradigm
- What is the Australian Securities Exchange (ASX)
- Why Genuine Parts Company Is a Royally Good Buy Right Now
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- Industrials Are Quietly Outpacing the Market: 3 Stocks to Watch
- Uptrend Stocks Explained: Learn How to Trade Using Uptrends
- These 5 Energy Stocks Hedge Inflation With Growth Potential
Receive News & Ratings for Veradigm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veradigm and related companies with MarketBeat.com's FREE daily email newsletter.
